Charles River Laboratories International Stock News

This global Pre Clinical CROs Services market report gives the end customers, which incorporates the business trained professionals, makers, retailers to choose the most recent things of market. The investigation framework uses a couple of perspectives for the combination of

New York State Teachers Retirement System boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 23.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 85,738 shares of the medical research companys stock after buying an additional 16,235 shares during the []

Kestra Advisory Services LLC lifted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 3.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,365 shares of the medical research companys stock after acquiring an additional 157 shares during the quarter. Kestra []

Arkadios Wealth Advisors decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL) by 61.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 75 shares of the medical research companys stock after selling 122 shares during the quarter. Arkadios Wealth []

Spire Wealth Management reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL) by 0.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 60,807 shares of the medical research company’s stock after selling 287 shares during the period. Spire […]

Bioanalytical Testing Services Market The bioanalytical testing services market was valued at USD 1,177.67 million in 2019 and is expected to grow with a CAGR of 13.4% during the forecast period. The ''Straits Research'' report focuses on target groups of customers to help players effectively market

Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global clinical laboratory services market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor. A clinical laboratory plays an integral role in the healthcare system of an economy as it provides a wide range of services, including the diagnosis, prevention, treatment, and management of patients. These services help healthcare professionals in medical decision-making and personalizing medicines based on the individuals'' needs and illness.

Csenge Advisory Group grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 2.9% in the 3rd quarter, Holdings Channel reports. The firm owned 1,712 shares of the medical research companys stock after acquiring an additional 49 shares during the quarter. Csenge Advisory Groups holdings in Charles River Laboratories International were worth []

Assenagon Asset Management S.A. decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL) by 44.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,591 shares of the medical research companys stock after selling 19,669 shares during the period. Assenagon []

Thrivent Financial for Lutherans lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL) by 17.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,792 shares of the medical research companys stock after selling 10,907 shares during the period. Thrivent []

Brandywine Oak Private Wealth LLC cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 3.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 763 shares of the medical research companys stock after selling 31 shares during the period. Brandywine Oak []

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Charles River (CRAI).

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The patient derived xenograft market size is anticipated to grow by USD 188.19 mn, progressing at a CAGR of 16.66% during the forecast period. This exclusive market forecast report by Technavio covers market scenarios, estimates, and customer

Koshinski Asset Management Inc. bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL) in the third quarter, HoldingsChannel reports. The fund bought 388 shares of the medical research company’s stock, valued at approximately $160,000. Several other hedge funds also recently bought and sold shares of CRL. Eaton Vance Management acquired a new stake […]